What is ELLXF's gross margin?

Elixinol (ELLXF) has a gross margin of 17% and a net margin of -15%.

What is ELLXF's P/E ratio?

Track Elixinol (ELLXF) P/E ratio, ROE, and valuation metrics over time.

Where can I see ELLXF's full financials?

See Elixinol (ELLXF) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Elixinol (ELLXF) Financials — Revenue, Earnings, Cash Flow

Also trades as: EXL.AX (ASX) · $vol 0M

$0.00

-0.00 (-14.88%)

Weekly Expected Move ±47.8%

$0 $0 $0 $0 $0

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 41 · $743508 mcap · 203M float · 0.0011% daily turnover · Short 49% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$31M

Revenue

+63.8% YoY

$-6M

Net Income

+59.6% YoY

$-5M

Free Cash Flow

+31.3% YoY

16.8%

Gross Margin

-8.4%

Op. Margin

-14.9%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-80.4%

ROA-40.5%

ROIC-69.0%

Valuation

P/E-0.7

P/B0.5

EV/EBITDA0.0

Leverage

Debt/Equity0.63

Current Ratio0.78

Interest Cov.-10.2x

Quality Scores

Piotroski F4/9

Altman Z—

Beneish M-1.25